ADENOVIRUS 243R E1A PROTEIN AND CELLULAR TRANSCRIPTION
ADENOVIRUS 243R E1A PROTEIN AND CELLULAR TRANSCRIPTION
批准号:
2895049
负责人:
DANIEL A ENGEL
金额:
$10.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-04-17 至 2000-03-31
关键词:
Adenoviridae HeLa cells cAMP response element binding protein gene induction /repression genetic regulatory element genetic transcription intermolecular interaction molecular cloning neoplasm /cancer genetics nucleic acid sequence plasmids protein structure function protooncogene reporter genes transcription factor viral carcinogenesis
中文摘要
对人类致癌机制的重要见解来自于
DNA肿瘤病毒的研究。 DNA肿瘤病毒腺病毒
提供了一个理想的系统,研究转录事件,
细胞转化 我们研究的长期目标是
了解腺病毒E1 A蛋白改变细胞增殖的机制。
正常的细胞转录程序,从而诱导转化。
在这里,我们集中在转录调控的细胞c-fos
腺病毒243 R E1 A蛋白与基因的功能相互作用
E1 A和细胞转录机制之间的联系。 我们以前的
研究已经确定了E1 A的作用与一个重要的
细胞内信号系统,cAMP依赖性蛋白激酶途径。
这种相互作用导致一组基因的激活,
参与细胞生长控制和转化。 获得的知识
通过研究E1 A对细胞转录调控的影响,
将导致更好地了解参与的分子事件,
转型
1)参与c-fos激活的识别性处理因子
通过E1 A和cAMP,一个22个核苷酸的“E1 A-反应元件”(ERE)已被
鉴定了通过243 R E1 A蛋白介导c-fos的激活。
ERE含有转录因子ATF/CREB的结合位点,
YY 1. 将确定与ERE结合的因素,并且E1 A的作用
和cAMP对它们的水平和活性的影响。
2)ATF/CREB-YY 1复合物的结构和功能。YY 1物理
与转录因子的AFT/CREB家族的成员相互作用。
作为研究ATF/CREB-YY 1复合物在
激活B E1 A,ATF/CREB-YY 1的结构/功能分析
将进行互动。 DNA结合和转录
还将研究复合物的抑制作用。
3)ATF/CREB-YY 1复合物作为E1 A的靶点。 E1 A可以与YY 1结合,
改变其DNA结合特性。 E1 A和YY 1之间的相互作用,
研究E1 A与ATF/CREB-YY 1复合物之间的相互作用。 实验
将包括E1 A-YY 1相互作用的结构/功能分析,
以及在体外和体内结合测定中。 这些实验将导致
E1 a激活thec-fos基因的分子基础的模型。
英文摘要
Important insights into the mechanisms of human carcinogenesis have come
from the study of DNA tumor viruses. The DNA tumor virus adenovirus
provides an ideal system for investigating transcriptional events in
cellular transformation. The long-term goal of our research is to
understnd the mechanism by which the adenovirus E1A protein alters the
normal cellular transcriptional program so as to induce transformation.
Here, we focus on the transcriptional regulation of the cellular c-fos
gene by the adenovirus 243R E1A protein, and the functional interaction
between E1A and the cellular transcriptional machinery. Our previous
studies have identified a link between the action of E1A and an important
intracellular signling system, the cAMP-dependent protein kinase pathway.
This interaction results in the activation of a set of genes that are
involved in cellular growth control and transformation. Knowledge gained
from studying the effects ofE1A on cellular transcriptional regulation
wil lead to better understanding of the molecular events involved in
transformation.
1) Identifiction transacting factors involved in the activation of c-fos
by E1A and cAMP, A 22 nucleotide "E1A-response element" (ERE) has been
identified that mediates activation of c-fos by the 243R E1A protein.
The ERE contains binding sites for transcription factors ATF/CREB and
YY1. Factors tht bind the ERE will be identified, and the effects of E1A
and cAMP on their level and activity will be determined.
2) Structure and function of the ATF/CREB-YY1 complex. YY1 physically
interacts with members of the AFT/CREB family of transcription factors.
As a prelude to investigating the role of the ATF/CREB-YY1 complex in
activation b E1A, structure/function analysis of the ATF/CREB-YY1
interaction will be performed. DNA-binding and transcriptional
repression by the complex will also be investigated.
3) The ATF/CREB-YY1 complex as a target ofE1A. E1A can bind to YY1 and
alter its DNA-binding properties. The interaction between E1A and YY1,
and between E1A and the ATF/CREB-YY1 complex will e studied. Experiments
will include structure/function analysis of the E1A-YY1 interaction, as
well as in itro and in vivo binding assays. These experiments will lead
to a model for the molecular basis of E1a activation of thec-fos gene.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Adenovirus E1A243 disrupts the ATF/CREB-YY1 complex at the mouse c-fos promoter.
腺病毒 E1A243 破坏小鼠 c-fos 启动子处的 ATF/CREB-YY1 复合物。
DOI:
10.1128/jvi.69.12.7402-7409.1995
发表时间:
1995
期刊:
Journal of virology
影响因子:
5.4
作者:
[Zhou,Q, Engel,DA]
通讯作者:
Engel,DA
Adenovirus E1A specifically blocks SWI/SNF-dependent transcriptional activation.
腺病毒 E1A 特异性阻断 SWI/SNF 依赖性转录激活。
DOI:
10.1128/mcb.16.10.5737
发表时间:
1996
期刊:
Molecular and cellular biology
影响因子:
5.3
作者:
[Miller,ME, Cairns,BR, Levinson,RS, Yamamoto,KR, Engel,DA, Smith,MM]
通讯作者:
Smith,MM
Adenovirus protein VII functions throughout early phase and interacts with cellular proteins SET and pp32.
腺病毒蛋白 VII 在整个早期阶段发挥作用,并与细胞蛋白 SET 和 pp32 相互作用。
DOI:
10.1128/jvi.79.4.2474-2483.2005
发表时间:
2005
期刊:
Journal of virology
影响因子:
5.4
作者:
[Xue,Yuming, Johnson,JeffreyS, Ornelles,DavidA, Lieberman,Judy, Engel,DanielA]
通讯作者:
Engel,DanielA
Human SWI-SNF component BRG1 represses transcription of the c-fos gene.
人类 SWI-SNF 成分 BRG1 抑制 c-fos 基因的转录。
DOI:
10.1128/mcb.19.4.2724
发表时间:
1999
期刊:
Molecular and cellular biology
影响因子:
5.3
作者:
[Murphy,DJ, Hardy,S, Engel,DA]
通讯作者:
Engel,DA
Adenovirus type 5 DNA-protein complexes from formaldehyde cross-linked cells early after infection.
感染后早期甲醛交联细胞中的 5 型腺病毒 DNA-蛋白质复合物。
DOI:
10.1016/s0042-6822(03)00194-6
发表时间:
2003
期刊:
Virology
影响因子:
3.7
作者:
[Spector,DavidJ, Johnson,JeffreyS, Baird,NicholasL, Engel,DanielA]
通讯作者:
Engel,DanielA
Small molecule inhibitors of influenza virus nucleoprotein
-
批准号:10255568
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2021
-
负责人:DANIEL A ENGEL
-
依托单位:
Discovery and development of broad spectrum anti-flaviviral drugs
-
批准号:8277243
-
项目类别:
-
资助金额:$83.53万
-
财政年份:2010
-
负责人:DANIEL A ENGEL
-
依托单位:
Discovery and development of broad spectrum anti-flaviviral drugs
-
批准号:8466918
-
项目类别:
-
资助金额:$76.44万
-
财政年份:2010
-
负责人:DANIEL A ENGEL
-
依托单位:
Discovery and development of broad spectrum anti-flaviviral drugs
-
批准号:8661106
-
项目类别:
-
资助金额:$82.68万
-
财政年份:2010
-
负责人:DANIEL A ENGEL
-
依托单位:
Discovery and development of broad spectrum anti-flaviviral drugs
-
批准号:8076338
-
项目类别:
-
资助金额:$84.44万
-
财政年份:2010
-
负责人:DANIEL A ENGEL
-
依托单位:
Discovery and development of broad spectrum anti-flaviviral drugs
-
批准号:7939155
-
项目类别:
-
资助金额:$86.91万
-
财政年份:2010
-
负责人:DANIEL A ENGEL
-
依托单位:
Development of Yeast-Based Assays for anti-influenza drug discovery
-
批准号:7153162
-
项目类别:
-
资助金额:$66.56万
-
财政年份:2006
-
负责人:DANIEL A ENGEL
-
依托单位:
Novel Tool Compounds for Chromatin Research
-
批准号:6735954
-
项目类别:
-
资助金额:$20.76万
-
财政年份:2004
-
负责人:DANIEL A ENGEL
-
依托单位:
CHROMATIN TARGETS FOR CANCER THERAPY
-
批准号:6189356
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2000
-
负责人:DANIEL A ENGEL
-
依托单位:
CHROMATIN TARGETS FOR CANCER THERAPY
-
批准号:6378054
-
项目类别:
-
资助金额:$26.64万
-
财政年份:2000
-
负责人:DANIEL A ENGEL
-
依托单位:
CHROMATIN TARGETS FOR CANCER THERAPY
-
批准号:6514674
-
项目类别:
-
资助金额:$26.64万
-
财政年份:2000
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEX
-
批准号:6287364
-
项目类别:
-
资助金额:$22.52万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEX
-
批准号:6624724
-
项目类别:
-
资助金额:$23.11万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS 243R E1A PROTEIN AND CELLULAR TRANSCRIPTION
-
批准号:2101428
-
项目类别:
-
资助金额:$10.45万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS 243R E1A PROTEIN AND CELLULAR TRANSCRIPTION
-
批准号:2390788
-
项目类别:
-
资助金额:$10.31万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEX
-
批准号:6685930
-
项目类别:
-
资助金额:$23.1万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEX
-
批准号:6475895
-
项目类别:
-
资助金额:$23.11万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEX
-
批准号:6836524
-
项目类别:
-
资助金额:$23.1万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS 243R E1A PROTEIN AND CELLULAR TRANSCRIPTION
-
批准号:2101429
-
项目类别:
-
资助金额:$10.34万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS 243R E1A PROTEIN AND CELLULAR TRANSCRIPTION
-
批准号:2683544
-
项目类别:
-
资助金额:$10.32万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
海外基金